Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
19,607,843
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
1,272,982
-
Shares change
-
+426,088
-
Total reported value, excl. options
-
$108,947,000
-
Value change
-
+$39,294,497
-
Number of buys
-
40
-
Number of sells
-
-18
-
Price
-
$85.59
Significant Holders of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) as of Q2 2021
62 filings reported holding ANVS - Annovis Bio, Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,272,982 shares
of 19,607,843 outstanding shares and own 6.49% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (229,453 shares), AIGH Capital Management LLC (126,469 shares), Ikarian Capital, LLC (103,527 shares), VOLORIDGE INVESTMENT MANAGEMENT, LLC (102,401 shares), BlackRock Inc. (100,997 shares), EAM Investors, LLC (48,643 shares), Knoll Capital Management, LLC (39,210 shares), GEODE CAPITAL MANAGEMENT, LLC (38,569 shares), Modera Wealth Management, LLC (34,746 shares), and Worth Venture Partners, LLC (33,834 shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.